The possibility of sAML transformed from a preexisting undiagnosed MPN was considered and supported by presence of persistent JAK2 V617F mutation, history of long standing gout, and marked thrombocytosis approximately 2 months before his AML presentation. Here, JAK2 is linked to myeloproliferative neoplasm.